Dong-A’s drug sales unlikely to top 1 trillion won

Dong-A Pharmaceutical Co., Korea’s largest drug producer, is unlikely to gain its membership in the 1-trillion won seller club this year in the aftermath of the government’s forced price cut for drugs and other medical products covered by National Health Insurance.

The Seoul-based firm yesterday said the revenue of Dong-A will reach 950 billion won this year as the overseas sales of its flag...